MedTrace Logo

Impact of Essure Tubal Sterilization Devices on the Endometrium

NCT01558882 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 2

Last updated 2017-06-19

No results posted yet for this study

Summary

The mobilization of natural killer cells (uNK) triggers and coordinates all stages of embryo implantation. They are at the origin of the local secretion of cytokines, growth factors, chemokines affecting vascular development and the local immunotrophisme for the conceptus. The main objective of this study is to evaluate the expression of endometrial uNK cells before and after tubal obstruction by Essure devices. Endoluminal and endometrial levels of various cytokines and growth factors will also be studied.

Conditions

  • Sterilization, Tubal

Interventions

DEVICE

Essure

Essure devices are deployed according to manufacturer's instructions for tubal sterilization.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • Vincent Letouzey, MD · Centre Hospitalier Universitaire de Nîmes

Eligibility

Min Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-21
Primary Completion
2014-11-28
Completion
2014-11-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01558882 on ClinicalTrials.gov